Laryngotracheal stenosis (LTS) is a critical narrowing of the glottis, subglottis, and/or trachea secondary to the development of pathologic fibrosis or scar. Laryngotracheal stenosis is most commonly a result of postintubation injury but can also be autoimmune related, radiation induced, or idiopathic.
1,2 The multiple consequences of LTS include communication handicap and airway obstruction, a potentially life-threatening complication if not managed appropriately.
1,3 The contemporary management of LTS is primarily surgical and includes serial dilation, tracheal or cricotracheal resection, laryngotracheoplasty, and/or permanent tracheostomy.
4,5 Medical therapies available for the management of LTS are limited, reflecting a need for improved understanding of disease pathogenesis.